CD2 and lymphoma: T-lymphoblastic leukemia/lymphoma is characteristically positive for T cell markers, including cytoplasmic CD3 (which is lineage-defining and specific), CD5, CD7, and CD2, which can all be assessed by flow cytometric analysis [3,20,21,22,23].